세계의 유전자 편집 시장(2025년) : 각종 기술 및 시장

The global market for genome editing is expected to grow from $10.8 billion in 2025 and is projected to reach $23.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 16.9% during the forecast period of 2025 to 2030.

The market for CRISPR-Cas genome editing technology is expected to grow from $7.8 billion in 2025 and is projected to reach $17.3 billion by the end of 2030, at a CAGR of 17.4% during the forecast period of 2025 to 2030.

The market for TALEN genome editing technology is expected to grow from $1.3 billion in 2025 and is projected to reach $2.7 billion by the end of 2030, at a CAGR of 15.6% during the forecast period of 2025 to 2030.

Report Scope

This report analyzes the market for genome editing technologies, applications and end users, offering insights into the market and technological trends. The study focuses on technologies such as CRISPR-Cas, transcription activator-like effector nucleases (TALEN) and zinc finger nucleases (ZFN), assessing their adoption in biopharmaceutical, agricultural biotech and research sectors. The market is segmented by applications into drug development, plant breeding, diagnostics and clinical therapy.

The report provides an analysis covering the regions of North America, Europe, Asia-Pacific and the Rest of the World (RoW), which includes Latin America, the Middle East and Africa. It evaluates the drivers, restraints, opportunities and challenges affecting the market and vendor landscape. It discusses clinical trials, patents and emerging technologies related to the market and looks at ESG-related developments.

The study offers an analysis of the competitive landscape, which ranks the top companies in the global market for genome editing. It also has a section with company profiles covering details of the market leaders. For market estimates, data has been provided for 2022 and 2023 as the historic years, 2024 as the base year, and forecasts for 2025 to 2030.

Report Includes

• 52 data tables and 58 additional tables
• A review of the global market for genome editing technologies
• Analyses of the global market trends, with market revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
• Evaluation and forecast of the genome editing market, and a corresponding market share analysis by product, application, end user and geographic region
• In-depth facts and figures concerning market drivers and deterrents, and other macroeconomic forces influencing the genome editing market
• A look at the use of clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9, and how it has fueled the growth of the genome editing industry
• An evaluation of the recent technological breakthroughs and issues, market regulations, and the current status of the intellectual property rights of the CRISPR-Cas9 genome editing technology
• Review of patent trends and research publications in the global genome editing industry
• Insight into the industry structure, competitive landscape, R&D activity, growth strategies and ESG trends
• Identification of the companies best positioned to meet market demand due to their proprietary technologies, mergers and acquisitions, joint ventures and other strategic alliances
• Profiles of the leading companies, including Merck KGaA, Thermo Fisher Scientific, Beam Therapeutics, CRISPR Therapeutics, and Cellectis S.A.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview and Market Definition
• Macroeconomic Factors
• Porter's Five Forces Model
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Potential for New Entrants
• Competition in the Industry
• Threat of Substitutes

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Prevalence of Genetic Disorders
• New Genome-Editing Technologies and Applications
• Increasing Government and Private Funding
• Market Restraints
• Governmental Policies and Regulations
• Ethical and Societal Concerns
• Market Opportunities
• Expanding Applications for CRISPR Technology
• Applications in Plant and Livestock Breeding
• Market Challenges
• Scalability Constraints in Gene Editing Workflows
• Cost of CRISPR-based Therapy

Chapter 4 Regulatory Landscape

• Regulatory Scenario, by Country/Region
• North America
• EU
• Asia-Pacific
• Rest of the World

Chapter 5 Emerging Technologies and Developments

• Emerging Technologies
• In Vivo Delivery of CRISPR
• Improved Cas Variants
• Artificial Intelligence
• Takeaways: Emerging Technologies in CRISPR
• Clinical Trials Analysis
• Clinical Trials Analysis, by Type of Study
• Clinical Trials Analysis, by Status
• Clinical Trials Analysis, by Phase
• Selected Clinical Trials
• Takeaways: Clinical Trials Landscape
• Patent Analysis
• Patents, by Year
• Patents, by Leading Applicant
• Patents, by Leading Patent Holder
• Recent Patents Relating to Genome Editing Technology
• IP Disputes and Patent Issues
• Key Takeaways: Patent Landscape (2020-2024)

Chapter 6 Market Segment Analysis

• Segmentation Breakdown
• Global Genome Editing Market, by Technology Type
• CRISPR-Cas
• TALEN
• ZFNs
• Other Genome Editing Platforms
• Global Genome Editing Market, by Application
• Drug Development
• Plant Breeding
• Diagnostics
• Clinical Therapy
• Other Applications
• Global Genome Editing Market, by End User
• Biopharmaceutical Companies
• Agricultural Biotechnology
• Research Institutions
• Other End Users
• Geographic Breakdown
• Global Genome Editing Market, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Intelligence

• Market Ranking Analysis
• Strategic Analysis
• Final Takeaways

Chapter 8 Sustainability in the Genome Editing Market: ESG Perspective

• Introduction to ESG
• Sustainability in Genome Editing: An ESG Perspective
• ESG Issues
• ESG Performance Analysis
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC

Chapter 9 Appendix

• Methodology
• References
• Abbreviations
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• BEAM THERAPEUTICS
• CARIBOU BIOSCIENCES INC.
• CELLECTIS S.A.
• CRISPR THERAPEUTICS
• EDITAS MEDICINE
• GENSCRIPT
• INTELLIA THERAPEUTICS INC.
• MERCK KGAA
• ORIGENE TECHNOLOGIES INC.
• PRECISION BIOSCIENCES
• SANGAMO THERAPEUTICS
• TAKARA BIO INC.
• THERMO FISHER SCIENTIFIC INC.
• VERVE THERAPEUTICS INC.